Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy

Authors
Hwang, Seung RimChakraborty, KushalAn, Jeong ManMondal, JagannathYoon, Hong YeolLee, Yong-kyu
Issue Date
2021-11
Publisher
MDPI
Citation
PHARMACEUTICS, v.13, no.11
Abstract
Drug delivery to tumor sites using nanotechnology has been demonstrated to overcome the drawbacks of conventional anticancer drugs. Altering the surface shape and geometry of nanocomposites alters their chemical properties, which can confer multiple attributes to nanocarriers for the treatment of cancer and their use as imaging agents for cancer diagnosis. However, heterogeneity and blood flow in human cancer limit the distribution of nanoparticles at the site of tumor tisues. For targeted delivery and controlled release of drug molecules in harsh tumor microenvironments, smart nanocarriers combined with various stimuli-responsive materials have been developed. In this review, we describe nanomaterials for smart anticancer therapy as well as their pharmaceutical aspects including pharmaceutical process, formulation, controlled drug release, drug targetability, and pharmacokinetic or pharmacodynamic profiles of smart nanocarriers. Inorganic or organic-inorganic hybrid nanoplatforms and the electrospinning process have also been briefly described here.
Keywords
SOLID LIPID NANOPARTICLES; DRUG-DELIVERY SYSTEMS; POLYMERIC MICELLE FORMULATION; CROSS-LINKED MICELLES; PHASE-II TRIAL; MAGNETIC NANOPARTICLES; INTRACELLULAR DELIVERY; ENHANCED PERMEABILITY; CREMOPHOR-FREE; GENEXOL-PM; pharmaceutical; nanocarrier; cancer; smart; polymer; lipid; virus; inorganic; hybrid; electrospinning
ISSN
1999-4923
URI
https://pubs.kist.re.kr/handle/201004/116166
DOI
10.3390/pharmaceutics13111875
Appears in Collections:
KIST Article > 2021
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE